Overheard: 2024 Houston Innovation Awards finalists share top advice for fellow founders

weighing in

Clockwise from top: Lori-Lee Elliot, Anwar Sadek, Mimi Healy, Ram Prasad, Tatiana Fofanova, Prabhdeep Sekhon, Raisha Smith, and Mitra Miller.

There's a great deal of advice swirling around the world today about how to find success business. Why not take it from mentors and founders with a proven track record, like the finalists for this year's Houston Innovation Awards?

From how to grow your customer base to tips on combating funding gaps and making room for yourself at the table, they shared priceless tokens of advice in their applications for the 2024 awards.

Here's what some of the leading founders and supporters in Houston's Innovation community had to say.

"Just because you don't look like everyone else in there room, or aren't offered a seat at the table, doesn't mean you don't deserve to be there. If anything, it means the world needs you there more."

–Lori-Lee Elliott, Co-Founder and CEO of Dauntless XR, female-founded business finalist

"Don’t shy away from seeking non-traditional forms of funding like grants and non-dilutive capital, especially if VC funding seems out of reach. Surround yourself with mentors who understand your challenges, and be intentional about expanding your network to build strategic connections. Above all, stay confident in your vision, use every opportunity to learn, and never hesitate to give back by helping othersalong the way. Your success not only opens doors for you but for future generations of minority founders."

-Anwar Sadek, CORROLYTICS CEO and co-founder, minority-founded business finalist

"Being an entrepreneur is fun and hard and exhilarating and frustrating and simple and complicated and joyful and exhausting and worth it. Make a plan so you can change your plan because the market changed, because the competition grew, because your data showed something different than what you expected, because you hired or lost a team member, because you raised more money, because you didn't raise enough money. Take the time to make the plan and think about all the ways it could change, so that whenit does, it is not the first time you thought about what to do because it will be too late."

–Mimi Healy, CEO of StimulusBio, mentor of the Year finalist

"My go-to advice for entrepreneurs is to prioritize their health while building their business. It’s easy to get caught up in the hustle, but long-term success comes from sustaining your physical and mental well-being. Entrepreneurs need to be at their best to make good decisions, lead effectively, and navigate challenges, so focusing on health isn’t just a luxury—it’s essential.Another key habit I always recommend is setting aside at least one hour a day to actively find new customers. Customer acquisition is the lifeblood of any business, and dedicating this time daily can help you build momentum, create relationships, and discover new opportunities that may have been overlooked."

–Ram Prasad, CEO of Delence, minority-owned business finalist

"Learn to sit on the other side of the table and think about things from the other person's perspective. When seeking funding, this means thinking about the investor's point of view. When selling, it means thinking about the customer's POV. How are you—the founder—helping them win?"

--Mitra Miller, Vice President of Houston Angel Network, mentor of the Year finalist

"Leverage the strength of your community. And as a founder, you are the secret sauce, not the imposter. Building a network of supportive peers and mentors who understand your unique challenges can be a game-changer. At EveryDopeGirl, we've seen how powerful it is when minority founders come together to share resources, insights, and encouragement. Don't hesitate to seek out and participate in events that foster these connections. Remember, your journey is not just about overcoming obstacles, but also about celebrating your successes and the unique perspectives you bring to the table."

-Raisha Smith, founder of EveryDopeGirl, female-founded business finalist

""Focus on your strengths rather than getting caught up in perceived gaps or doubts. Embrace the diversity in your team, just as we’ve done at Gold H2, where 50 percent of our team is female and 80 percent are visible minorities. Diversity brings strength ... Trust yourself, and don’t be afraid to shape your journey in both your career and personal life."

–Prabhdeep Sekhon, CEO of Gold H2, minority-owned business finalist

"Surround yourself with two types of people: the lovers and the fighters. First, surround yourself with people that love you and believe in your vision–they'll be the ones who pick you up when your spirit takes a beating and you feel like giving up. Second, surround yourself with those who you can categorically trust to fight to the bitter end-when life happens, they'll be the ones running the ship andkeeping the dream alive while you sort things out. These will almost never be the same people, so you have to find both."

-Tatiana Fofanova, CEO of Koda Health, female-founded business finalist

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings